Sixty-seven galactose negative (Gal-) clones were established from survivors The existence of regulatory genes in mammalian systems has been suggested from studies with both intact organisms and somatic cells, but as yet there is no report on the experimental induction of regulatory mutations in mammalian cells. In a preceding paper of this series (1), we reported the mutagenic effect of a combined treatment of Chinese hamster cells in culture with 5-bromodeoxyuridine (BrdU) and black light.
Permeation of galactose into mutant cells appeared unimpaired. In intra-and interspecific cell hybrids, the mutation causing the Gal-phenotype behaved like a recessive character. The pleiotropic nutritional response was due not to deficiency of any one specific enzyme in the Leloir pathway but to significant reduction in activities of phosphoglucomutase, NADP-dependent isocitrate de- hydrogenase, and perhaps other enzymes. In temperaturesensitive Gal-mutants grown at permissive temperature or in complementing intra-and interspecific cell hybrids, the activities of these enzymes were restored to normal levels, accompanied by a regained ability to use the particular hexoses or hexose monophosphates.
We postulate that the change from Gal+ to Gal-phenotype in hamster cells could be due to mutations at a regulatory gene locus, or at a yet unknown locus with enzymic defect that causes secondary metabolic imbalances.
The existence of regulatory genes in mammalian systems has been suggested from studies with both intact organisms and somatic cells, but as yet there is no report on the experimental induction of regulatory mutations in mammalian cells. In a preceding paper of this series (1), we reported the mutagenic effect of a combined treatment of Chinese hamster cells in culture with 5-bromodeoxyuridine (BrdU) and black light.
Several kinds of auxotrophic variants were isolated; those incapable of utilizing exogenous galactose were especially prevalent. Sixty-one galactose-negative (Gal-) variants, henceforth referred to operationally as mutants, were isolated from 12 mutagenesis experiments. Six additional Gal-mutants were obtained in two subsequent experiments. This paper describes the growth behavior and biochemical and genetic characterization of representative Gal-mutants.
Abbreviations: Gal + or -, ability or inability to utilize galactose; ts, temperature-sensitive, Gal-i-PUT, galactose-1-phosphate uridylyltransferase; UDPGppase 20 ,000 X g for 20 min. The supernatant fluid was either assayed immediately or stored in liquid nitrogen. Protein content of the lysate was determined by the biuret method (6) . The prepared crude extract contained about 3-6 mg/ml of protein. The activities of the enzymes studied remained unchanged in extracts stored for several months.
Enzyme Assays. The assay method for galactokinase (EC 2.7.1.6) was that of Cuatrecasas and Segal (7) . A rate reaction method (8) was used for assaying galactose-l-P uridylyltransferase (Gal-i-PUT, EC 2.7.7.12). The activities of this and other following enzymes were measured in a Beckman Acta II recording spectrophotometer at 37°. The assay procedure for UDPglucose pyrophosphorylase (UDPGppase, EC 2.7.7.9) was a modification of that of Hansen et al. (9) . The assay method for phosphoglucomutase (PGM, EC 2.7.5.1) and galactose 4-epimerase (epimerase, EC 5.1.3.2) were modified from those described by Beutler (10) . The assay method for NADP+-dependent isocitrate dehydrogenase (IDH, EC 1.1.1.42) was a modification of that of Cleland et al. (11) .
In Vitro Heat Inactivation of PGM and IDH. Crude cell extracts containing about 3-6 mg of protein per ml were diluted 1:10 with 1 M glycylglycine buffer, pH 8.7. This crude extract was inactivated at 620. At 5-min intervals, 10-,ul samples were withdrawn, transferred to chilled cuvettes containing the reaction mixture, and assayed for the activity of PGM. In the case of IDH, cell extract was diluted 1:10 with 1 M Tris buffer (pH 7.0), inactivated for various times at 500 or 420, and assayed.
Starch difference in uptake and incorporation between wild-type (22,000 cpm/mg of protein) and mutant cell lines (21,000-31,000 cpm/mg of protein) incubated at these temperatures. Thus, the Gal-mutants do not appear to be defective in transport of galactose into the cell.
The parental cells were capable of utilizing either fructose, glucose 1-P, glucose 6-P, or galactose 1-P. In contrast, 27 randomly selected Gal-mutants could not utilize any of these compounds, given either alone or in various combinations. Nontoxic levels of either 1 mM 3':5'-cyclic adenosine monophosphate (cAMP) or 0.1 mM dibutyryl cAMP in the medium that contained galactose or any of these carbohydrates did not support growth of the mutants.
Reversion Studies. Twenty-seven Gal-mutant clonal cell lines tested all reverted spontaneously, regaining their ability to utilize exogenous galactose. The frequency of reversions varied from 10-v to 10-5, and was stable among subclones.
Twelve revertants from Gal-2 and 20 revertants from Gal-3 exhibited a complete restoration to the wild-type phenotype in terms of nutritional requirement and enzyme activities.
Activities of IDH and of Enzymes Involved in Galactose Metabolism. Interspecific Cell Hybrid Between Chinese Hamster GalactoseNegative Mutant and Human Lymphocyte. In the progeny of an interspecific is hybrid that was formed between a hamster Gal-2 cell and a human lymphocyte, a subelone was isolated that contained a single human chromosome (A2), in addition to the entire hamster chromosome complement (4). This "alien-addition" hybrid clone, designated GJ-1, could utilize exogenous galactose (or other carbohydrates tested) and contained both human and hamster forms of Gal-l-PUT, as well as a heteropolymer probably formed by enzyme subunits of both species. We concluded from this study that the human structural gene for Gal-i-PUT is located on chromosome A2 (4) .
The activities of the six enzymes of GJ-1 were assayed and the results are also shown in Table 1 . The activities of galactokinase, Gal-l-PUT and epimerase remained at the same level in this hybrid as in one of its parents, Gal-2. On the other hand, the activities of PGM, IDH, and UDPGppase in the hybrid were much higher than those in Gal-2, if not up to the levels of V79 cells. It should be pointed out that although only one human chromosome was present in this cell hybrid, GJ-1 grew at a slower rate than the parental hamster cells. As it is usually the case for slow growing cells (including those grown at 330), the total cellular protein content is higher than in rapidly growing cells. The enzyme ac- § C. C. Chang, N. C. Sun, and E. H. Y. Chu, manuscript in preparation. Average of eight non-ts Gal-mutants, (B) average of three ts Gal-mutants grown at 370, (C) average of the three ts Galmutants grown at 330, (D) average of seven complementing hamster-hamster cell hybrids, (E) human-hamster cell hybrid GJ-1, (F) a subelone of GJ-1 that had concurrently lost the ability to use galactose and human chromosome A2. Error bars delimit standard deviation.
tivities of GJ-1 on a per cell basis should, therefore, be higher than was apparent. In any event, the concurrent increase of PGM, IDH, and UDPGppase activities in GJ-1 hybrid cells was apparently sufficient for their survival and continued proliferation in media containing galactose or other carbon sources. In two of the subclones that had lost A2 chromosome together with ability to use galactose (4), IDH activity returned to the same low level as Gal-2 (Fig. 1) .
The activities of galactokinase, epimerase, PGM, IDH, and UDPGppase in GJ-1 cells were also studied by starch gel electrophoresis. On the zymograms the GJ-1 cells exhibited the presence of hamster forms of these enzymes but the absence of homologous human enzymes. This contrasts clearly with the electrophoretic patterns of Gal-i-PUT of the GJ-1 cells, in which the characteristic bands of activities from both species were present.
DISCUSSION
The criteria for genetic alterations in mammalian somatic cells in culture have been discussed elsewhere (13, 14) . The genetic origin of the Gal-mutants is supported, though not proven, by (a) induction after mutagenic treatment (1), (b) stable phenotype in cell progeny in the absence of selection, (c) the existence of temperature-sensitive mutants, (d) genetic complementation, and (e) chromosomal assignment of a human homologous gene.
Cell hybrids formed between two complementing Galmutant hamster cells or between a Gal-mutant cell and a Gal+ hamster or human cell invariably exhibited Gal+ phenotype, indicating the recessive character of the Gal-mutations. It is not known whether these mutations existed in homozygous or hemizygous state. In any case, on the basis of the frequency at which they were detected and single-step reversion to wild type, the Gal-phenotype was probably the result of single-gene mutations and it is unlikely that multiple gene loci were involved. If recurrent Gal-mutations occurred at the same locus, genetic complementation in hamster-hamster tetraploid cell hybrids formed by two complementing Galmutants can be interpreted by conformation correction of defective protein subunits derived from each parental mutant cell (15) .
In the interspecific cell hybrid, GJ-1, in which only one extra human chromosome, A2, was present in addition to the full hamster complement, there was electrophoretic evidence for the presence of human Gal-i-PUT (4), but absence of human galactokinase, epimerase, UDPGppase, PGM, and IDH (this study). Thus, this interspecific hybrid's ability to utilize galactose was not due to activation of this group of human enzymes. Moreover, although the chromosome location of the human gene for epimerase is not known, the structural gene loci for human PGM-1 (16) and UDPGppase (17) have been assigned to human chromosome Al and the gene for galactokinase to chromosome E17 (18) . On the other hand, the presence of the single human A2 chromosome in GJ-1 cells is associated concordantly with the increase in the activities of all three hamster enzymes examined (PGM, IDH, and UDPGppase) such that this particular cell hybrid can grow and proliferate in the galactose medium. Therefore, the homologous human gene which compensates the hamster Gal-mutation is located on chromosome A2.
The inability of Gal-mutants to utilize exogenous galdctose was probably not due to defects in its transport into the cell. We found that both mutant and nonmutant hamster cells took up radioactive galactose with comparable efficiency. It has been shown in cultured human fibroblasts derived from galactosemic patients that the uptake of galactose across the cell membrane was unobstructed (19) .
The pleiotropic effect suggests the possibility that the Gal-mutations might be analogous to adenylate cyclase mutants in Escherichia coli (20, 21) , which exhibit multiple nutritional responses. Our preliminary experiments, however, failed to demonstrate growth of Gal-mutants in galactose medium supplemented by either cAMP or dibutyryl cAMP. Although no direct measurement of adenylate cyclase activity was made in the mutant hamster cells, the possibility that they were mutations at this locus seems to be remote.
There was no appreciable difference in Gal-i-PUT activities among all cell lines studied. The activities of galactokinase and epimerase were lower in Gal-mutants than those in parental cells. The activities of the two enzymes were not restored to normal level in either interspecific or intraspecific hybrids, yet these hybrids survived well in galactose medium. These results support the electrophoretic evidence that the primary defect of Gal-mutations did not involve enzymes in the Leloir pathway. Furthermore, on the basis of heat inactivation data and the absence of homologous human enzymes in GJ-1 hybrid, the Gal-mutations were probably not at the gene loci for PGM and IDH. This conclusion is also supported by the observations in other organisms that allelic complementation did not generally yield more than 25% of the normal wild-type level of enzyme activity (15) . In complementing hamster cell hybrids, the PGM and IDH activity were elevated to the normal levels (Fig. 1) .
The present data may be explained by assuming that the 
